Pseudomonas aeruginosa bacteremia: Clinical and epidemiological patterns and treatment. A 7-year prospective study;Bacteriemias por pseudomonas aeruginosa: Epidemiología, clínica y tratamiento. Estudio prospectivo de siete años

Revista Espanola de Quimioterapia

Volumn 15, Issue 4, 2002, Pages 360-365

  Gómez, Joaquin ^b   Alcantara M ^b   Simarro, E ^b   Martinez B ^b   Ruiz, J ^b   Guerra, B ^b   Gomez Vargas J ^b   Valdes M ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b NONE

Author keywords

Bacteremia; Gram negative infections; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ADULT; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BLOOD CULTURE; CARDIOMYOPATHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; FEMALE; GRAM NEGATIVE INFECTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEOPLASM; NEPHROSIS; NONHUMAN; POSTOPERATIVE COMPLICATION; PROGNOSIS; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SYMPTOMATOLOGY;

BACTEREMIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSEUDOMONAS INFECTIONS; TIME FACTORS;

EID: 0036998605     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Bodey, G.P., Bolívar, R., Fainstein, V., Jadeja, L. Infections caused by Pseudomonas aeruginosa. Rev Infect Dis 1983; S: 279-313.
2. Bodey, G.P., Jadeja, L., Elting, L. Pseudomonas bacteriemia. Retrospective analysis of 410 episodes. Arch Intern Med 1985; 145: 1621-1629.
3. Gómez, J., Casas, I., Ruiz, J. y cols. Bacteriemias por Pseudomonas aeruginosa en un hospital general. Enf Infec Microbiol Clin 1988; 60: 460-463.
4. Gómez, J., Moldenhauer, F., Ruiz, J. y cols. Valoración de la monoterapia con ceftazidima en bacteriemias por Pseudomonas aeruginosa. Estudio prospectivo. Med Clin 1989; 93: 249-251.
5. Grupo de Estudio de las Bacteriemias (coordinador F. Martínez Luengas). Bacteriemias en seis hospitales españoles. Med Clin (Barc) 1986; 86: 221-232.
6. Yu, V.L., Paterson, D.L. Pseudomonas aeruginosa. En: Yu, V.L., Merigan, T.C., Jr., Barriere, S.L. (Eds.). Antimicrobial therapy and vacines. Williams & Wilkins, Baltimore 1999: 348-359.
7. Van Uethem, L, Lagast, H., Klastersky, J. Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against P. aeruginosa and K. pneumoniae. Antimicrob Agents Chemother 1983; 23: 435-439.
8. th ed. Churchill Livingstone, Philadelphia 2000; 2: 2310-2335.
9. Meyers, B.R., Sherman, E., Mandelson, M.H. y cols. Bloodstream infections in the elderly. Am J Med 1989; 86: 379-385.
10. McGowan, J.E., Barnes, M.W., Finland, M. Bacteremia at the Boston City Hospital: Occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital acquired cases. J Infect Dis 1975; 132: 316-335.
11. Games, J.S., Jarvis, W.R., Emori, T.G., Horan, T.C., Hughes, J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-140.
12. Gómez, J., Alemán, A., Hernández, J.L. y cols. Sepsis en un departamento de Medicina Interna. An Med Intern 1990; 7: 28-33.
13. Jacobs, E.R., Bone, R.C. Clinical indicators in sepsis and septic adults respiratory distress syndrome. Med Clin North Am 1986; 70: 921-932.
14. McCabe, W.R., Jackson, G.G. Gram negative bacteriemia. I. Etiology and ecology. Arch Intern Med 1962; 110: 847-855.
15. Winston, D.J., Murphy, W., Young, L.S. y cols. Piperacillin therapy for serious bacterial infections. Am J Med 1980; 69: 255-261.
16. Mallolas, J., Gatell, J.M., Miró, J.M. y cols. Epidemiologic characteristics and factors influencing the outcome of Pseudomonas aeruginosa bacteremia. Rev Infect Dis 1990; 12: 718-719.
17. Beam, T.P., Gilbert, D.N., Kunin, C.M. General guidelines for the clinical evaluation of antiinfective drug products. Clin Infect Dis 1992; 15 (Suppl. 1): S5-S32.
18. Bisbe, J., Gatell, J.M., Puig, J. y cols. Pseudomonas aeruginosa bacteremia: Univariate and multivariate analyses of factors influencing the prognosis in 133 episodes. Rev Infect Dis 1988; 10: 629-635.
19. Gallagher, P.G., Watanakunakorn, C. Pseudomonas bacteremia in a community teaching hospital, 1980-1984. Rev Infect Dis 1989; 11: 846-852.
20. Vázquez, F., Mendoza, M.C., Vila, M., Trivindel, A., Méndez, F.I. Characteristics of Pseudomonas aeruginosa strains causing septicemia in a Spanish hospital, 1981-1990. Eur J Clin Microbiol Infect Dis 1992; 11: 698-703.
21. Vidal, F., Mensa, J., Almela, M. y cols. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes. Arch Intern Med 1996; 156: 2121-2126.
22. Weinstein, N.T., Reller, L.B., Murphy, J.R., Lichtenstein, K.A. The clinical significance of positive blood cultures: A comprehensive analysis of 500 episodes of bacteremia and funguemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 1983; 5: 35-53.
23. Bouza, E., Pérez-Molina, J., Muñoz, P., Cooperative Group of the European Study Group on Nosocomial Infections (ESGNI). Report of ESGNI-001 and ESGNI-002 studies. Bloodstream infections in Europe. Clin Microbiol Infect 1999; S: 2S1-2S12.
24. Gómez, J., Moldenhauer, F., Hernández, J.L. y cols. Bacteriemias en un departamento de cirugía. Epidemiología y análisis de factores pronóstico. Estudio prospectivo 1987. Cirugía Española 1991; 49: 38-42.
25. Gómez, J., Martínez, C., Moldenhauer, F. y cols. Epidemiología y facfores pronóstico de las bacteriemias en un Departamento de Medicina Interna. Estudio prospectivo durante 1987. Rev Esp Microbiol Clin 1990; 5: 39-44.
26. Baltch, A.L., Griffin, P.E. Pseudomonas aeruginosa bacteremia: A clinical study of 75 patients. Am J Med Sci 1977; 274: 119-129.
27. Kreger, B.E., Craven, D.E., Curling, P.C. y cols. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med 1980; 68: 332-343.
28. Cross, A., Allen, J.R., Burke, J. y cols. Nosocomial infection due to Pseudomonas aeruginosa: Review of recent trends. Rev Infect Dis 1983; 5 (Suppl. 5): 5837-5845.
29. McManus, A.T., Mason, Jr., A.D., McManus, W.F., Pruitt, Jr., B.A. Twenty-five years review of Pseudomonas aeruginosa bacteremia in burn center. Eur J Clin Microbiol 1985; 4: 219-223.
30. Richard, P., Le Floch, R., Chamoux, C. y cols. Pseudomomas aeruginosa outbreak in a burn unit: Role of antimicrobials in the emergence of multiple resistant strains. J Infect Dis 1994; 170: 377-383.
31. Meyer, C.N., Skinhoj, P., Pragg, J. Bacteremia in HIV-positive and AIDS patients: Incidence, species distribution, risk-factors, outcome, and influence of long-term prophylactic antibiotic treatment. Scand J Infetc Dis 1994; 26: 635-642.
32. Kirkpatrick, B.L., Glover, S.C., Reeves, D.S., McGowan, A.P. Microbiologically proven bacterial infections in AIDS. Postgrad Med J 1997; 73: 565-570.
33. Dropulic, L.K., Leslie, M., Eidred, L.J., Zenilman, J., Sears, C.L. Clinical manifestations and risk factors of Pseudomonas aeruginosa infection in patients with AIDS. J Infect Dis 1995; 171: 930-937.
34. Fichtenbaum, C.J., Woeltje, K.F., Powderly, W.G. Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: A case-control study. Clin Infect Dis 1994; 19: 417-422.
35. Mendelson, M.H., Gurtman, A., Szabo, X. Pseudomonas aeruginosa bacteremia in patients with AIDS. Clin Infect Dis 1994; 18: 886-895.
36. Nelson, M.R., Shanson, D.C., Barter, G.J. y cols. Pseudomonas septicaemia associated with HIV. AIDS 1991; 5: 761-763.
37. Vidal, F., Mensa, J., Martínez, J.A. y cols. Pseudomonas aeruginosa bacteremia in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 1999; 18: 473-477.
38. Siegman-Igra, Y., Ravona, R., Primerman, H., Giladi, M. Pseudomonas aeruginosa bacteremia: An analysis of 123 episodes with particular emphasis on the effect of antibiotic therapy. Int J Infect Dis 1998; 2: 11-15.
39. Hilf, M., Yu, V.L. Sharp, J. y cols. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: Outcome correlation in a prospective study of 200 patients. Am J Med 1989; 87: 540-546.
40. Mallolas, J., Gatell, J.M., Miró, J.M. y cols. Analysis of prognostic factors in 274 consecutive episodes of Pseudomonas aeruginosa bacteremia. Antibiot Chemother 1991; 44: 106-114.
41. Gransden, W.R., Leibovici, L., Eykyn, S.J. y cols. Risk factors and a clinical index for diagnosis of Pseudomonas aeruginosa bacteremia. J Clin Microbiol Infect 1996; 1: 119-123.
42. Leibovici, L. Greenshtain, S., Cohen, O., Mor, F., Wysenbeek, A.J. Bacteremia in febrile patients. A clinical model for diagnosis. Arch Intern Med 1991; 151: 1801-1806.
43. Forkner, C.E., Frei, E., Edgcomb, H. y cols. Pseudomonas septicemia: Observations on twenty-three cases. Am J Med. 1958; 25: 877-889.
44. Weinstein, M.P., Towns, M.L., Quartey, S.M. y cols. The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and funguemia in adults. Clin Infect Dis 1997; 24: 584-602.
45. Kreger, B.E., Craven, D.E., McCabe, W.R. Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 1980; 68: 344-355.
46. Gatell, J.M., Trilla, A., Latorre, X., Almela, M., Mensa, J., Moreno, A. Nosocomial bacteremia in a large Spanish teaching hospital: Analysis of factors influencing prognosis. Rev Infect Dis 1988, 10: 203-210.
47. Villar, A., Blanes, A., Sánchez, J. y cols. A prognostic multifactorial study of sepsis in an internal medicine service. An Med Intern 1993; 10: 107-112.
48. Whitelaw, D.A., Rayner, B.L., Willcox, P.A. Community-adquired bacteremia in the elderly: A prospective study of 121 cases. J Am Geriatr Soc 1992; 40: 996-1000.
49. Richardson, J.P. Bacteremia in the elderly. J Gen Intern Med 1993; 8: 89-92.
50. Kuikka, A., Valtonen, W. Factors associated with improved outcome of university Pseudomonas aeruginosa bacteremia in a Finnish hospital. Eur J Clin Microbiol Infect Dis 1998; 17: 701-8.
51. Leibovici, L., Paul, M., Poznanski, O. y cols. Monotherapy versus βlactam aminoglycoside combination treatment for gram-negative bacteremia: A prospective observational study. Antimicrob Agents Chemother 1997; 41: 1127-1133.
52. Gómez, J., Moldenhauer, F., Ruiz, J. y cols. Monoterapia (ceftazidima) versus combinaciones (ceftazidina+amikacina) en bacteriemias por gramnegativos. Estudio prospectivo y aleatorio 1987. Rev Esp Quimioterap 1990; 3: 35-40.
53. Uzun, O., Akalin, H.E., Hayran, M., Unal, S. Factors influencing prognosis in bacteremia due to gram-negative organisms: Evaluation of 448 episodes in a Turkish university hospital. Clin Infect Dis 1992; 15: 866-873.
54. Todeschini, G., Franchini, M., Tecchio, C. y cols. Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 consecutive neutropenic patients with hematologic malignancies. Int J Infect Dis 1998-1999; 3: 99-104.
55. Chen, S.C., Lawrence, R.H., Byth, K., Sorrell, T.C. Pseudomonas aeruginosa bacteremia. Is pancreatobiliary disease a risk factor? Med J Austral 1993; 159: 592-597.